Skip to main content
Log in

Reply to: kynurenic acid and alcohol and cocaine dependence: novel effects and multiple mechanisms?

  • Commentary
  • Published:
Psychopharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Badawy AA (2016) Kynurenic acid and alcohol and cocaine dependence: novel effects and multiple mechanisms? Psychopharmacology (in press)

  • Badawy AA, Bano S, Steptoe A (2011) Tryptophan in alcoholism treatment I: kynurenine metabolites inhibit the rat liver mitochondrial low km aldehyde dehydrogenase activity, elevate blood acetaldehyde concentration and induce aversion to alcohol. Alcohol Alcohol 46:651–660

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Birch PJ, Grossman CJ, Hayes AG (1988) Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor. Eur J Pharmacol 154:85–87

    Article  CAS  PubMed  Google Scholar 

  • Chiarugi A, Cozzi A, Ballerini C, Massacesi L, Moroni F (2001) Kynurenine 3-mono-oxygenase activity and neurotoxic kynurenine metabolites increase in the spinal cord of rats with experimental allergic encephalomyelitis. Neuroscience 102:687–695

    Article  CAS  PubMed  Google Scholar 

  • Chiarugi A, Moroni F (1999) Quinolinic acid formation in immune-activated mice: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[−N-4-(−3-nitrophenyl)thiazol-2yl]-benzenesul fonamide (Ro 61-8048), two potent and selective inhibitors of kynurenine hydroxylase. Neuropharmacology 38:1225–1233

    Article  CAS  PubMed  Google Scholar 

  • de Carvalho LP, Bochet P, Rossier J (1996) The endogenous agonist quinolinic acid and the non endogenous homoquinolinic acid discriminate between NMDAR2 receptor subunits. Neurochem Int 28:445–452

    Article  PubMed  Google Scholar 

  • Moroni F, Cozzi A, Carpendo R, Cipriani G, Veneroni O, Izzo E (2005) Kynurenine 3-mono-oxygenase inhibitors reduce glutamate concentration in the extracellular spaces of the basal ganglia but not in those of the cortex or hippocampus. Neuropharmacology 48:788–795

    Article  CAS  PubMed  Google Scholar 

  • Okuda S, Nishiyama N, Saito H, Katsuki H (1996) Hydrogen peroxide-mediated neuronal cell death induced by an endogenous neurotoxin, 3-hydroxykynurenine. Proc Natl Acad Sci U S A 93:12553–12558

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schwarcz R, Bruno JP, Muchowski PJ, Wu HQ (2012) Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci 13:465–477

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Vécsei L, Szalárdy L, Fülöp F, Toldi J (2013) Kynurenines in the CNS: recent advances and new questions. Nat Rev Drug Discov 12:64–82

    Article  PubMed  Google Scholar 

  • Vengeliene V, Cannella N, Takahashi T, Spanagel R (2016) Metabolic shift of the kynurenine pathway impairs alcohol and cocaine seeking and relapse. Psychopharmacology 233:3449–3459

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Valentina Vengeliene.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vengeliene, V. Reply to: kynurenic acid and alcohol and cocaine dependence: novel effects and multiple mechanisms?. Psychopharmacology 234, 167–168 (2017). https://doi.org/10.1007/s00213-016-4489-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-016-4489-1

Keywords

Navigation